Search

everythinglearnresearchcommunity

for

Search:↓

A protein from certain immune cells is key for new hair growth after skin injury in mice.

Trilostane effectively and safely treats dogs with pituitary-dependent hyperadrenocorticism, improving symptoms and adrenal gland size.

Zinc is crucial for nutrition, especially in patients with specific health conditions, and requires careful supplementation and monitoring.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

HIV can cause various severe or unusual skin conditions that help indicate the presence and stage of the disease.

Cyclosporine A can reduce inflammation in dogs with sebaceous adenitis, but ongoing treatment is needed.

Retinoids increase steroid sulfatase activity in leukemia cells through RARα/RXR and involves certain pathways like phosphoinositide 3-kinase and ERK-MAP kinase.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

Hair loss is a rare but recognized symptom of pemphigus vulgaris, with patients usually regrowing hair after treatment.

Treatment can improve survival and symptoms in dogs with Cushing's disease, but outcomes are unpredictable.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.

Chronic kidney disease can cause skin problems that affect patient quality of life, and treating these conditions can improve outcomes.

Platelet-rich plasma therapy could be an effective treatment for melasma with minimal side effects.

Active oxygen species might be involved in skin tumor growth, but their exact role is unclear.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

Effective symptom management in IBD improves quality of life and prevents complications.

The report suggests that hair loss in Cronkhite-Canada syndrome may be caused by alopecia areata incognita, as shown by a patient's improvement with treatment.

Indian men have 62.1% hair loss, mostly grade II vertex, and less extensive than other populations.

Early diagnosis, intensive therapy, and careful follow-up are crucial for managing overlapping TTP and SLE.

Histopathology is not reliable for detecting early fibrosis in traction alopecia or for showing how severe it is.

Chemotherapy and radiotherapy can cause skin side effects like rashes, hair loss, and nail changes, which are usually managed with conservative treatments.

KAP-depleted hair causes less immune response and is more biocompatible for implants.

Cinnamaldehyde helps bone healing initially but may slow healing later unless combined with DHT treatment.

MSC-derived exosomes can help treat COVID-19, hair loss, skin aging, and arthritis.

Skin healing from blisters can delay hair growth as stem cells focus on repairing skin over developing hair.

The meeting showcased rare skin disease cases, highlighting the need for accurate diagnosis and treatment.

The document reports unique growth lines in a child after Stevens-Johnson syndrome, skin reaction from parsnips and sun in a girl, and itchy skin with xanthomas in a boy with Alagille syndrome.

The meeting presented findings on effective treatments for various pet skin conditions and insights into the immune responses of dogs with atopic dermatitis.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.